[HPV vaccines--effect, safety and cost-effectiveness].
Gjertsen
Marianne Klemp
MK
Neilson
Aileen Rae
AR
de Blasio
Birgitte Freiesleben
BF
D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D053918:Papillomavirus Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D012449:Safety; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control / Q000821:virology
D053918:Papillomavirus Vaccines